Ocugen, Inc.
OCGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $4 | $6 | $2 | $0 |
| % Growth | -32.8% | 142.6% | – | – |
| Cost of Goods Sold | $2 | $1 | $0 | $0 |
| Gross Profit | $2 | $5 | $2 | $0 |
| % Margin | 51.5% | 88.3% | 100% | – |
| R&D Expenses | $32 | $40 | $56 | $35 |
| G&A Expenses | $27 | $32 | $35 | $23 |
| SG&A Expenses | $27 | $32 | $35 | $23 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$2 | -$1 | $0 | $0 |
| Operating Expenses | $57 | $71 | $92 | $58 |
| Operating Income | -$55 | -$66 | -$89 | -$58 |
| % Margin | -1,350.4% | -1,085.7% | -3,580% | – |
| Other Income/Exp. Net | $1 | $2 | $2 | -$0 |
| Pre-Tax Income | -$54 | -$63 | -$87 | -$58 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$54 | -$63 | -$87 | -$58 |
| % Margin | -1,333% | -1,045% | -3,488.9% | – |
| EPS | -0.2 | -0.26 | -0.4 | -0.3 |
| % Growth | 23.1% | 35% | -33.3% | – |
| EPS Diluted | -0.2 | -0.26 | -0.4 | -0.3 |
| Weighted Avg Shares Out | 271 | 244 | 215 | 195 |
| Weighted Avg Shares Out Dil | 271 | 244 | 215 | 195 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $3 | $1 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $2 | $1 | $0 | $0 |
| EBITDA | -$53 | -$65 | -$89 | -$58 |
| % Margin | -1,301.8% | -1,074% | -3,560.7% | – |